Silberman David 4
4 · ORAMED PHARMACEUTICALS INC. · Filed May 31, 2023
Insider Transaction Report
Form 4
Silberman David
Chief Financial Officer
Transactions
- Award
Common Stock
2023-05-26+24,500→ 230,000 total
Footnotes (1)
- [F1]Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis.